Previous 10 | Next 10 |
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will participate in the 2021 Jefferies London Healthcare Conference. A virtual fireside chat will be available to conference attendees...
The following slide deck was published by Spectrum Pharmaceuticals, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Spectrum Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation
Image source: The Motley Fool. Spectrum Pharmaceuticals, inc (NASDAQ: SPPI) Q3 2021 Earnings Call Nov 10, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Spectrum Pharmaceuticals, inc (SPPI) Q3 2021 Earnings Call Tr...
Spectrum Pharmaceuticals, Inc. (SPPI) Q3 2021 Earnings Conference Call November 10, 2021, 04:30 PM ET Company Participants Joseph Turgeon - President and Chief Executive Officer Kurt Gustafson - Executive Vice President and Chief Financial Officer Francois Lebel - Executive Vice President and...
Shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) are up 5% in after-hours trading after beating Q3 2021 EPS estimates. On a GAAP basis, the company's net loss in the quarter narrowed ~32% year over year to $33.1M (-$0.21 per basic and diluted share). The company ended the quarter wi...
Spectrum Pharmaceuticals (NASDAQ:SPPI): Q3 Non-GAAP EPS of -$0.16 beats by $0.09; GAAP EPS of -$0.21 beats by $0.07. Revenue of $0M misses by $0.52M. Press Release The company ended the quarter with cash, cash equivalents, and marketable securities of $133.6 million. For further details see...
Poziotinib NDA is on track for submission in 2021 under a Fast Track designation Positive front line poziotinib data presented at ESMO Congress 2021 from Cohort 4 of the ZENITH20 clinical trial Preclinical data presented at 2021 AACR-NCI-EORTC (Triple) conference demon...
OTCQX:ACRGF, ADMA, AEVA, DADAAMPE, AMWL, APP, APPH, ASND, ATO, OTCPK:ATUSF, AZUL, BANX, BARK, BIOL, BKEP, BMBL, BOXL, BRFS, BRKS, BROS, BSQR, BW, BYND, BZH, CBAY, CCCS, CCMP, CGRN, CLSD, CLVR, CRCT, CYCC, DARE, DGII, DIS, EDRY, EGLX, ELMS, ENS, EVOK, FICO, FIGS, FOSL, FSM, GAU, GDRX, GEVO, OT...
If you’re like most traders in the stock market today, you’re on the hunt for the best penny stocks to buy now. Heading into the remainder of the week, there are plenty of different trends to follow. Following this week’s FOMC meeting, many expect a Santa Claus rally go...
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2021 financial results and provide a corporate update on Wednesday, November 10, 2021 at 4...
News, Short Squeeze, Breakout and More Instantly...
Spectrum Pharmaceuticals Inc. Company Name:
SPPI Stock Symbol:
NASDAQ Market:
Spectrum Pharmaceuticals Inc. Website:
New York, New York--(Newsfile Corp. - December 14, 2022) - Levi & Korsinsky, LLP notifies investors in Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI) of a class action securities lawsuit. The lawsuit on behalf of Spectrum investors has been commenced in the the...
NEW YORK, NY / ACCESSWIRE / December 12, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ:SPPI) and reminds investors of the February 3, 2023 deadline to seek th...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Spectrum To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - December 7, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...